Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at StockNews.com
Analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Trading Up 1.6% Shares of Brooklyn ImmunoTherapeutics stock opened at $6.85 on Friday. The firm has a market capitalization of $402.96 […]
